News

Uranium is shifting back into favour with investors as spot prices reflect positive signals for demand from the nuclear power ...
Wall Street’s flying but the ASX skids this morning. Life360 rockets again, while stocks like Macquarie and Aristocrat stumble.
Several ASX-listed companies have partnered with Cell Therapies, based at Peter Mac to manufacture CAR-T and other cell ...
America's 90-day trade-war truce with China has jolted markets awake and reset the narrative for investors, traders and ...
Brazilian Critical Minerals (ASX:BCM) has started the crucial in-situ recovery field trial at its Ema rare earths project in ...
Core Lithium has laid out a $200 million plan to steer its Finniss project in the Northern Territory back to production if the market turns.
In a world first, Compumedics has shown that its MEG brain scanning tool can image adults and children at the same time.
Amid declining reserves and surging demand, Andromeda is turning up the heat on kaolin with its development-ready Great White asset.